FDA Submission Expected This Summer - Invest Before It Happens
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Shares Stats
| Shares Outstanding | 146,500,000 |
| Shares Float | 146,250,000 |
| Shares Short | 3,390,000 |
| Insider Holdings | 19% |
| Institution Holdings | 92.80% |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS; and TOFIDENCE, a tocilizumab biosimilar referencing ACTEMRA. It offers RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, and biosimilars. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; and Sage Therapeutics, Inc., as well as collaborations with Fujirebio to identify and develop biomarkers for tau pathology in the brain and Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 7,605 |
Highlights
| Analyst Target | 170.22 |
| Market Cap | 19,469,200,000 |
| PE Ratio | 13.12 |
| PEG Ratio | 6.24 |
| EBITDA | 3,080,900,096 |
Financials
| Curr Year EPS Estimate | 14.83 |
| Next Quarter EPS Estimate | 4.07 |
| Profit Margin | 15.73% |
| Operating Margin | 22.62 |
| Return on Assets | 0.05 |
| Return on Equity | 0.09 |
| Revenue | 9.4B |
| Earnings Per Share | 10.12 |
| Revenue Per Share | 67.32 |
| Gross Profit | 7,426,200,064 |
| Quarterly Revenue Growth | 0.06 |
Valuation
| Trailing PE | 13.13 |
| Forward PE | 8.90 |
| Price/Sales (Trailing 12 Mt.) | 1.98 |
| Price/Book (Most Recent Quarter) | 1.15 |
Earnings
Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not
WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.
Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys
Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs.
Buffett's Next Big Investment... Is It This Gold Play? - Ad
Buffett's $325B cash pile is losing value fast - and one gold miner could be his next move. It trades at a 43% discount to its free cash flow, and fits his criteria to a T. With gold set to soar and valuations stretched, now's your chance to front-run Buffett before August 15.
Marjorie Taylor Greene: 'Muslim Takeover' Threatens American Women
Rep. Marjorie Taylor Greene (R-Ga.) has expressed her fears regarding what she believes to be the most significant threat to the freedom of American women.
Mystery Seller Behind $105 Million Plot Next to Jeff Bezos Estate Finally Revealed
A plot of land neighboring Jeff Bezos' property in Miami was sold for a staggering $105 million. The undeveloped lot was sold by German investor Mikhail Peleg.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
Sig Sauer, faced with lawsuits over a popular pistol, gets protection in New Hampshire
CONCORD, N.H. (AP) — Faced with mounting lawsuits over a popular pistol, New Hampshire-based Sig Sauer asked for — and got — protection in the form of a new state law that makes it harder to .
Kevin O'Leary Once Said That Business School Graduates Know Nothing Until The Real World Smacks Them, Something He Learned The Hard Way— Now He Can Spot A Winner In 15 Minutes Flat
Kevin O'Leary says real-world experience—not business school—taught him to trust his intuition, which now allows him to spot winning entrepreneurs in just 15 minutes with near-perfect accuracy.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Goldman Just Launched Two New Bond ETFs; Here's Why Investors Should Pay Attention
Goldman Sachs Asset Management debuts two new actively managed fixed income ETFs in response to rising demand for active strategies in a volatile rate landscape.
Bye Bye Birdie: Twitter Blue Bird Logo Blown Up To Promote Online Marketplace Company
Elon Musk bought Twitter for $44 billion and rebranded it to X, auctioning off old memorabilia like the iconic blue bird logo. Ditchit, the buyer of the logo, recently blew it up in a promotional stunt.
Wall Street Says BUY GOLD, But... - Ad
While markets wobble, gold keeps smashing records-and banks say it's just beginning. Goldman urges "buy gold" to hedge trade wars; JPMorgan plans $6,000 an ounce and just took delivery of $4 billion in bullion. Yet past bull runs saw 13x-1,000x bigger gains without buying more gold.
Asian shares are mixed after US stocks hit an all-time high
BANGKOK (AP) — Asian shares started the week with gains after U.S. stocks closed at an all-time high following their recovery from the shocks of the Trump administration’s
Drone debris found in Ukraine indicates Russia is using new technology from Iran
Last week, Ukrainian drone hunters picking up the debris from Russia’s nightly assault on their cities found a weapon that stood out from the rest.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
One Tech Tip: No more lost cats and dogs. Use tech to track your pet
LONDON (AP) — “Have you seen the cats?”
Home to North Carolina iconic attraction reopens after Hurricane Helene's devastation
CHIMNEY ROCK, N.C. (AP) — An iconic tourist attraction in an area of western North Carolina among the hardest hit by reopened to the public on Friday, nine months after the storm brought historic flooding, destruction and loss of life.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Amazon's AI-Powered 4-Day Prime Day Will Drive Billions In Sales
Bank of America analyst maintains Buy rating on Amazon with $248 price forecast, noting 11th Prime Day event to have extended 4-day window with AI savings tools and estimated $21.4B in GMV.
States brace for impact as Trump's big bill nears completion in Congress
JEFFERSON CITY, Mo. (AP) — President Donald Trump’s and reduce federal spending on some social safety net programs could have large implications for states, but for many it’s too late to do much about it this year.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox.
Senate GOP removes tax on solar and wind energy but dismantles climate law passed by Democrats
WASHINGTON (AP) — The approved by the Senate Tuesday removes a proposed tax on solar and wind energy projects but quickly phases out tax credits for wind, solar and other renewable energy.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
On This Day 15 Years Ago, Elon Musk's Tesla Took A Risk On The Public Markets — Now It's Paid Off Nearly 300 Times Over
Tesla marks its 15th anniversary of its IPO with a staggering 300-fold surge in its stock value.
Trump Says Israel Ready For 60 Day Ceasefire In Gaza, Hopes Hamas Takes The Deal Because It Won't 'Get Better'
Trump proposed 60-day ceasefire in Gaza, which Israel has agreed to. Qatar and Egypt will deliver the proposal to Hamas. Trump meets Netanyahu next week.
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Big Banks Pass Fed's 2025 Stress Test With Ease—But Some Say It Was Too Easy
All major U.S. banks passed the Fed's 2025 stress test, but critics say easier assumptions may have padded the results.
Asian shares mostly higher after US stocks hit another record as Tesla and Nike rally
MANILA, Philippines (AP) — Asian shares mostly gained on Thursday after U.S. stocks hit another all-time high.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Donald Trump Drops Hint About Potential TikTok Buyer, But Keeps Details Close To His Chest
President Trump has indicated the presence of a potential buyer for the US operations of TikTok.
Supreme Court takes up a Republican appeal to end limits on party spending in federal elections
WASHINGTON (AP) — will take up a Republican-led drive, backed by President Donald Trump's administration, to wipe away limits on how much political parties can spend in coordination with candidates for Congress and president.
Buffett's Next Big Investment... Is It This Gold Play? - Ad
Buffett's $325B cash pile is losing value fast - and one gold miner could be his next move. It trades at a 43% discount to its free cash flow, and fits his criteria to a T. With gold set to soar and valuations stretched, now's your chance to front-run Buffett before August 15.
Trump's Tariffs, Boeing's Blowout, Tesla's Robotaxi, BYD's European Triumph And GM's Massive Recall: This Week In Mobility
This week's business and finance highlights include Japan's rejection of Trump's auto tariffs, Boeing's scrutiny over a mid-air incident, Tesla's Robotaxi launch, BYD's dominance in Europe, and GM's massive vehicle recall.
Dalai Lama To Deliver Major Address On 90th Birthday As China Tracks Succession Moves
The 14th Dalai Lama will address a major three-day gathering of Buddhist religious figures this week ahead of his 90th birthday.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON (AP) — said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.
Senate Republicans move to slash CFPB funding by half, risking hundreds of job cuts
NEW YORK (AP) — Senate Republicans have moved to cut the funding of the Consumer Financial Protection Bureau by roughly half, as part of President Trump’s “Big Beautiful Bill,” which is likely to lead to hundreds of job cuts at the nation’s financial watchdog agency.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Trump's Crypto Advisor David Sacks Says July Will Be A 'Big Month' — Says President Supports Legislation On Market Structure And Stablecoins
President Donald Trump's crypto and AI advisor, David Sacks, praised on Thursday the Senate’s timeline and plan for crypto legislation that proposes dividing oversight of digital assets between market regulators.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.